D-0507-2024 Class II Terminated

Recalled by American Regent, Inc. — New Albany, OH

FDA drug recall D-0507-2024 was initiated by American Regent, Inc. on May 13, 2024 and is designated Class II. Reason for recall: Subpotent product in addition to having out-of-specification results for impurities. The recall status is terminated (terminated Dec 22, 2025). Affected quantity: 2,352 vials.

Recall details

Product Type
Drugs
Report Date
May 29, 2024
Initiation Date
May 13, 2024
Termination Date
Dec 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,352 vials

Product description

Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01

Reason for recall

Subpotent product in addition to having out-of-specification results for impurities.

Distribution pattern

USA Nationwide

Code information

Lot #: 23061L1C0, Exp 1/31/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0507-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0507-2024. Report a data issue: hello@regdatalab.com.